N
Natco Pharma Ltd
Pharmaceuticals
SMALLCAP
Pharmaceuticals
Live Performance vs
This is a tool to communicate factual return information and should not be seen as an advertisement or promotion
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 13.16 | 41.34 |
| PB Ratio | 3.75 | 5.97 |
| Dividend Yield | 0.95% | 0.61% |
Understand what these metrics mean.
About the company
N
Natco Pharma Ltd
Natco Pharma Limited is a research and development (R&D)-focused pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceu...
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions